Summary
One of the most exciting and useful advances in nuclear cardiology is the opportunity to measure myocardial blood flow (MBF) routinely as part of myocardial perfusion imaging (MPI) with positron emission tomography (PET). Incorporating MBF into the MPI evaluation improves diagnosis and assessment of extent and severity of epicardial coronary artery disease (CAD), reclassifies prognosis from assessment based solely on perfusion defects, confirms effectiveness of pharmacologic stress, and can identify coronary microvascular disease with or without epicardial CAD. Read more.
Resource Type
Guidelines, Information Statements
Clinical Topic
Cardiac PET, Myocardial Blood Flow (MBF), Myocardial Perfusion Imaging (MPI)
Year Published
2021
Related Resources
PET Case: This is Why We Do Cardiac PET: Comparison of SPECT and PET in the Same Patient
Case summary: A 60-year-old patient with recurring exertional angina undergoes cardiac PET…
PET Case: Atrial Septal Hypertrophy Masquerading as Potential Malignancy: Role of PET Imaging
Case summary: This case highlights the role of cardiac PET/CT in evaluation…
Support Patient Access to Care Through Physician Payment Stability and Adequacy
ASNC May 2026 Physician Payment Fact Sheet